Literature DB >> 6309891

Plasma adrenocorticotropin and cortisol responses to intravenous injection of corticotropin-releasing factor in the morning and evening.

T Tsukada, Y Nakai, T Koh, S Tsujii, H Imura.   

Abstract

Plasma ACTH and cortisol responses to corticotropin-releasing factor (CRF) were determined in the morning and evening in seven normal men. Either 100 micrograms synthetic ovine CRF or saline was given intravenously at 0900 h and at 2200 h. Blood samples were collected before and 15, 30, 45, 60, 90, and 120 min after CRF or saline injection. Plasma ACTH concentrations before and after CRF injection in the morning were significantly higher (P less than 0.05) than those in the evening at all times except 45 min after injection. Plasma cortisol concentrations before and at all times after CRF injection in the morning were also significantly higher (P less than 0.05) than those in the evening. However, neither the maximum increments in plasma ACTH and cortisol above the control levels nor increments at each time point following CRF injection in the morning differed significantly from those in the evening. Increments in the area under the ACTH and cortisol concentration curves after CRF injection in the morning also did not differ significantly from those in the evening. These results suggest that the responsiveness of the pituitary to CRF in the morning and in the evening does not differ significantly, although actual values of plasma ACTH and cortisol are higher in the morning.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309891     DOI: 10.1210/jcem-57-4-869

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

Authors:  M Nink; U Krause; H Lehnert; J Beyer
Journal:  Klin Wochenschr       Date:  1991-03-18

2.  Comparison of endocrinological stress response associated with transvaginal ultrasound-guided oocyte pick-up under halothane anaesthesia and neuroleptanaesthesia.

Authors:  Y Naito; S Tamai; J Fukata; N Seo; Y Nakai; H Imura; K Mori
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

3.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

Authors:  N S Schwartz; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Corticotropin-releasing factor and adrenal function in major depression.

Authors:  D Nerozzi; G Bersani; E Melia; A Magnani; I Antonozzi; G Frajese
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

5.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Corticotropin- and growth hormone-releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases.

Authors:  K von Werder; O A Müller
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.